CLINICAL-LABORATORY, IMMUNOLOGICAL, PATHOGENETIC MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME AND IDENTIFICATION OF EFFECTIVE TREATMENT REGIMENS (REVIEWS)

Authors

  • Musakov Mirzokhid Sabitdjanovich Tashkent Medical Academy, Tashkent, Uzbekistan
  • Samatova Lobar Dilmurodovna Tashkent Medical Academy, Tashkent, Uzbekistan
  • Turaxojaeva Sabokhat Sultanshikovna Tashkent Medical Academy, Tashkent, Uzbekistan
  • Salaeva Muborak Saidabdullayevna Tashkent Medical Academy, Tashkent, Uzbekistan
  • Tursunova Minavvar Ulug’bekovna Tashkent Medical Academy, Tashkent, Uzbekistan

Keywords:

antiphospholipid syndrome (APS), antiphospholipid antibodies, lupus anticoagulant.

Abstract

Antiphospholipid syndrome (APS) is one of the leading causes of thrombosis. According to some estimates, the incidence of APS is about 5 new cases per 100,000 people per year and the prevalence is about 40-50 cases per 100,000 people [1], thus the problem of APS remains one of the most important in medicine.

Downloads

Published

2023-05-12

Issue

Vol. 15 (2023)

Section

Articles

How to Cite

CLINICAL-LABORATORY, IMMUNOLOGICAL, PATHOGENETIC MANIFESTATIONS OF ANTIPHOSPHOLIPID SYNDROME AND IDENTIFICATION OF EFFECTIVE TREATMENT REGIMENS (REVIEWS). (2023). Spectrum Journal of Innovation, Reforms and Development, 15, 51-61. https://sjird.journalspark.org/index.php/sjird/article/view/643